Snap-8
Octapeptide-2 — the most advanced topical anti-wrinkle peptide for expression line reduction.
Key Benefits
competes with SNAP-25 to reduce neuromuscular contraction intensity at wrinkle sites
clinical studies show up to 63% reduction in wrinkle depth with consistent use
delivers botulinum toxin-like effects without needles or systemic risk
improves overall skin smoothness and reduces the appearance of crow's feet and forehead lines
Active Signaling Pathway
Investigated Pathways
Proposed Mechanism
Snap-8 works by competing with SNAP-25 for a position in the SNARE complex, which is responsible for the release of neurotransmitters at the neuromuscular junction. By partially blocking this complex, Snap-8 reduces the intensity of muscle contractions that cause dynamic wrinkles. Unlike botulinum toxin, Snap-8 does not permanently block neurotransmitter release — it modulates it, making it a safer cosmetic alternative.
Research Highlights
- In vitro studies show Snap-8 reduces SNAP-25 by up to 52.7% in neuronal cell cultures
- Clinical studies demonstrate up to 63% reduction in wrinkle depth with twice-daily topical application
- Shown to be 30% more effective than Argireline (Acetyl Hexapeptide-3) in reducing expression lines
- Well-tolerated with no systemic absorption — ideal for sensitive skin formulations
Evidence is primarily from in vitro cell studies and animal models. Human data is limited or absent.
For laboratory research only
All Research Systems →For research use only — not for human consumption. No treatment claims.
Full Research Hub →Recommended Stacks
Snap-8 is a key compound in these curated research stacks. Pair it with synergistic peptides for enhanced outcomes.
Radiant Skin & Anti-Aging
Target every layer of skin aging simultaneously — structural, regenerative, and oxidative.
How long will one vial last?
Based on standard research protocols, here's exactly what to expect from a single 10mg vial — and when to plan your next order.
Vial supply estimate is based on standard research protocol volumes. Actual duration will vary based on your specific protocol design.
Scientific Background
Mechanism of Action
Snap-8 works by competing with SNAP-25 for a position in the SNARE complex, which is responsible for the release of neurotransmitters at the neuromuscular junction. By partially blocking this complex, Snap-8 reduces the intensity of muscle contractions that cause dynamic wrinkles. Unlike botulinum toxin, Snap-8 does not permanently block neurotransmitter release — it modulates it, making it a safer cosmetic alternative.
Clinical Context
Snap-8 is widely used in cosmeceutical formulations at concentrations of 3–10%. Research protocols use it as a lyophilized powder reconstituted in sterile water for topical or mesotherapy application. It is particularly effective when combined with hyaluronic acid or collagen-stimulating peptides.
Research Highlights
- In vitro studies show Snap-8 reduces SNAP-25 by up to 52.7% in neuronal cell cultures
- Clinical studies demonstrate up to 63% reduction in wrinkle depth with twice-daily topical application
- Shown to be 30% more effective than Argireline (Acetyl Hexapeptide-3) in reducing expression lines
- Well-tolerated with no systemic absorption — ideal for sensitive skin formulations
Storage & Reconstitution
Key Studies
Inhibition of neuronal exocytosis by a peptide acting on the SNARE complex
Blanes-Mira C et al.
Snap-8 reduced SNAP-25 activity by up to 52.7% in neuronal cell cultures, demonstrating potent SNARE complex inhibition.
PubMed →Clinical evaluation of Snap-8 for wrinkle reduction
Lim SH et al.
Twice-daily topical Snap-8 application reduced wrinkle depth by up to 63% over 28 days in clinical evaluation.
Topical peptides as cosmeceuticals
Gorouhi F et al.
Snap-8 is 30% more effective than Argireline (Acetyl Hexapeptide-3) for expression line reduction due to its longer 8-residue sequence.
PubMed →Pharmacokinetics
Bioavailability indicates how much of the compound reaches systemic circulation. Peak plasma is when blood levels are highest. Half-life determines dosing frequency — compounds with short half-lives require more frequent dosing to maintain therapeutic levels.
The volume of distribution reflects how widely the compound distributes into tissues. A higher Vd means the compound concentrates in tissues rather than staying in plasma.
Receptor Binding Profile
Blocks SNARE complex formation, reducing acetylcholine vesicle release at neuromuscular junction
Reduces facial muscle contraction intensity at expression lines
Indirect collagen production improvement via reduced mechanical stress on dermis
Side Effects & Adverse Events
- Mild skin irritation at application site
- Redness
- Contact dermatitis (rare)
- None documented
Contraindications & Interactions
Synergistic Compounds
GHK-Cu addresses structural skin aging (collagen/elastin) while Snap-8 targets dynamic expression lines — comprehensive anti-aging.
GHK-Cu topical AM + Snap-8 topical PM for full-spectrum skin research.
View Compound →GLOW blend contains Leuphasyl (similar mechanism to Snap-8); standalone Snap-8 amplifies expression line reduction.
GLOW blend AM + Snap-8 topical PM for comprehensive anti-aging protocol.
View Compound →Transparent Global Sourcing
Manufactured
Sourced through our manufacturing partner in China
Independent Testing
Analytical reports available from Janoshik Analytical
Batch Verification
Batch-specific COAs with online verification via janoshik.com
US Fulfillment
Orders fulfilled from the United States